| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.03e-07 | 4 | 75 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.01e-06 | 6 | 75 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.04e-06 | 129 | 75 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.22e-05 | 151 | 75 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.99e-05 | 18 | 75 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 1.10e-04 | 25 | 75 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.12e-04 | 31 | 75 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.56e-04 | 33 | 75 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 8.97e-04 | 12 | 75 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.23e-03 | 14 | 75 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.35e-03 | 58 | 75 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.80e-03 | 465 | 75 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.83e-03 | 343 | 75 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.91e-03 | 140 | 75 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.93e-03 | 749 | 75 | 9 | GO:0005509 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 8.08e-06 | 11 | 77 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.77e-05 | 14 | 77 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | response to caffeine | 6.34e-05 | 21 | 77 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | metal ion transport | ATP7A TMC2 MS4A2 NKAIN4 SLC24A4 PKD2L1 NKAIN1 NKAIN3 PLP1 RYR1 RYR2 AMIGO1 RYR3 | 7.75e-05 | 1000 | 77 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 8.21e-05 | 4 | 77 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 9.03e-05 | 493 | 77 | 9 | GO:0010959 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.06e-04 | 392 | 77 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | maintenance of location | 1.14e-04 | 396 | 77 | 8 | GO:0051235 | |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 2.52e-04 | 33 | 77 | 3 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 2.52e-04 | 33 | 77 | 3 | GO:0022010 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 2.93e-04 | 577 | 77 | 9 | GO:0043269 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP7A TMC2 MS4A2 NKAIN4 SLC24A4 PKD2L1 NKAIN1 NKAIN3 PLP1 RYR1 RYR2 AMIGO1 RYR3 | 3.27e-04 | 1157 | 77 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.55e-04 | 37 | 77 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.80e-04 | 8 | 77 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 4.15e-04 | 39 | 77 | 3 | GO:1903514 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.53e-04 | 73 | 77 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | junctional membrane complex | 4.74e-04 | 9 | 77 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 5.91e-04 | 10 | 77 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 6.10e-04 | 45 | 77 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 6.51e-04 | 46 | 77 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | microfibril | 1.02e-03 | 13 | 77 | 2 | GO:0001527 | |
| Domain | Ryanrecept_TM4-6 | 5.73e-08 | 3 | 73 | 3 | IPR009460 | |
| Domain | RyR | 5.73e-08 | 3 | 73 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.73e-08 | 3 | 73 | 3 | IPR003032 | |
| Domain | RR_TM4-6 | 5.73e-08 | 3 | 73 | 3 | PF06459 | |
| Domain | Ryan_recept | 5.73e-08 | 3 | 73 | 3 | IPR013333 | |
| Domain | NKAIN | 2.29e-07 | 4 | 73 | 3 | PF05640 | |
| Domain | Na/K-Atpase_Interacting | 2.29e-07 | 4 | 73 | 3 | IPR008516 | |
| Domain | RIH_assoc | 1.14e-06 | 6 | 73 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.14e-06 | 6 | 73 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.14e-06 | 6 | 73 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.14e-06 | 6 | 73 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.14e-06 | 6 | 73 | 3 | IPR015925 | |
| Domain | - | 1.14e-06 | 6 | 73 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.14e-06 | 6 | 73 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.14e-06 | 6 | 73 | 3 | PF08709 | |
| Domain | MIR | 6.74e-06 | 10 | 73 | 3 | PS50919 | |
| Domain | MIR | 6.74e-06 | 10 | 73 | 3 | PF02815 | |
| Domain | MIR | 6.74e-06 | 10 | 73 | 3 | SM00472 | |
| Domain | MIR_motif | 6.74e-06 | 10 | 73 | 3 | IPR016093 | |
| Domain | FBN | 4.51e-05 | 3 | 73 | 2 | IPR011398 | |
| Domain | ARM-type_fold | 5.22e-05 | 339 | 73 | 8 | IPR016024 | |
| Domain | DUF1981 | 9.00e-05 | 4 | 73 | 2 | PF09324 | |
| Domain | Sec7_N | 9.00e-05 | 4 | 73 | 2 | IPR032691 | |
| Domain | Sec7_N | 9.00e-05 | 4 | 73 | 2 | PF12783 | |
| Domain | DCB_dom | 9.00e-05 | 4 | 73 | 2 | IPR032629 | |
| Domain | DCB | 9.00e-05 | 4 | 73 | 2 | PF16213 | |
| Domain | Sec7_C | 9.00e-05 | 4 | 73 | 2 | IPR015403 | |
| Domain | TB | 3.12e-04 | 7 | 73 | 2 | PF00683 | |
| Domain | SPRY | 3.74e-04 | 87 | 73 | 4 | SM00449 | |
| Domain | - | 4.16e-04 | 8 | 73 | 2 | 3.90.290.10 | |
| Domain | SPRY | 5.02e-04 | 94 | 73 | 4 | PF00622 | |
| Domain | SPRY_dom | 5.02e-04 | 94 | 73 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 5.23e-04 | 95 | 73 | 4 | IPR001870 | |
| Domain | B302_SPRY | 5.23e-04 | 95 | 73 | 4 | PS50188 | |
| Domain | TB | 5.33e-04 | 9 | 73 | 2 | PS51364 | |
| Domain | TB_dom | 5.33e-04 | 9 | 73 | 2 | IPR017878 | |
| Domain | EF-hand-dom_pair | 8.98e-04 | 287 | 73 | 6 | IPR011992 | |
| Domain | - | 1.53e-03 | 15 | 73 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.53e-03 | 15 | 73 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.53e-03 | 15 | 73 | 2 | IPR023394 | |
| Domain | Sec7 | 1.75e-03 | 16 | 73 | 2 | SM00222 | |
| Domain | SEC7 | 1.75e-03 | 16 | 73 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.75e-03 | 16 | 73 | 2 | IPR000904 | |
| Domain | EF_hand_dom | 2.14e-03 | 232 | 73 | 5 | IPR002048 | |
| Domain | - | 3.56e-03 | 261 | 73 | 5 | 1.10.238.10 | |
| Domain | ARM-like | 4.11e-03 | 270 | 73 | 5 | IPR011989 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | IPR026823 | |
| Domain | cEGF | 4.61e-03 | 26 | 73 | 2 | PF12662 | |
| Domain | Ig_I-set | 6.54e-03 | 190 | 73 | 4 | IPR013098 | |
| Domain | ig | 6.54e-03 | 190 | 73 | 4 | PF00047 | |
| Domain | Immunoglobulin | 6.54e-03 | 190 | 73 | 4 | IPR013151 | |
| Domain | I-set | 6.54e-03 | 190 | 73 | 4 | PF07679 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 3.40.1110.10 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 2.70.150.10 | |
| Domain | EF-hand_8 | 7.80e-03 | 34 | 73 | 2 | PF13833 | |
| Domain | ATPase_P-typ_cyto_domN | 8.25e-03 | 35 | 73 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 8.71e-03 | 36 | 73 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 8.71e-03 | 36 | 73 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 8.71e-03 | 36 | 73 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.19e-03 | 37 | 73 | 2 | IPR008250 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 7.21e-06 | 11 | 51 | 3 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.24e-05 | 13 | 51 | 3 | M39589 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 2.93e-05 | 17 | 51 | 3 | M2482 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.15e-05 | 19 | 51 | 3 | M47760 | |
| Pathway | WP_GLIAL_CELL_DIFFERENTIATION | 3.54e-04 | 8 | 51 | 2 | M39372 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.23e-04 | 176 | 51 | 5 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.05e-04 | 183 | 51 | 5 | M997 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18403125 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.04e-08 | 3 | 77 | 3 | 9204703 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 7876312 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.04e-08 | 3 | 77 | 3 | 12213830 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 9242641 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.04e-08 | 3 | 77 | 3 | 10788707 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.04e-08 | 3 | 77 | 3 | 7621815 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18643873 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.04e-08 | 3 | 77 | 3 | 10473538 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.04e-08 | 3 | 77 | 3 | 4600883 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 7635066 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18206662 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 4.17e-08 | 4 | 77 | 3 | 23413940 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 9384575 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 9607712 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 23482488 | ||
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.04e-07 | 5 | 77 | 3 | 19011160 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 2.08e-07 | 6 | 77 | 3 | 26025922 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 2.08e-07 | 6 | 77 | 3 | 14592808 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.08e-07 | 6 | 77 | 3 | 25966694 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.08e-07 | 6 | 77 | 3 | 16844763 | |
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 11860456 | ||
| Pubmed | A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase. | 3.63e-07 | 7 | 77 | 3 | 17606467 | |
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.80e-07 | 8 | 77 | 3 | 19033399 | |
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 11784029 | ||
| Pubmed | 2.26e-06 | 12 | 77 | 3 | 19095005 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12399449 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21851253 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12429739 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 4.84e-06 | 2 | 77 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 4.84e-06 | 2 | 77 | 2 | 21440062 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15131124 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 36354016 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 4.84e-06 | 2 | 77 | 2 | 21531043 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16678258 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 4.84e-06 | 2 | 77 | 2 | 12524050 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 4.84e-06 | 2 | 77 | 2 | 20404337 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12565913 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9489997 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 4.84e-06 | 2 | 77 | 2 | 8791520 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17259277 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 4.84e-06 | 2 | 77 | 2 | 12640042 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8120105 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 4.84e-06 | 2 | 77 | 2 | 8307578 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 4.84e-06 | 2 | 77 | 2 | 14722100 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 4.84e-06 | 2 | 77 | 2 | 10504303 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 4.84e-06 | 2 | 77 | 2 | 26009179 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 7556644 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32899693 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14592949 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 4.84e-06 | 2 | 77 | 2 | 7744963 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26408953 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23918382 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8898078 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 4.84e-06 | 2 | 77 | 2 | 18006876 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 4.84e-06 | 2 | 77 | 2 | 15894801 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30542613 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 4.84e-06 | 2 | 77 | 2 | 24833718 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17360629 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14550562 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10716990 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 4.84e-06 | 2 | 77 | 2 | 11673493 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11673462 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9799464 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24265020 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18203920 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 4.84e-06 | 2 | 77 | 2 | 25524144 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9817784 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23133647 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 4.84e-06 | 2 | 77 | 2 | 25370123 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10212200 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 14985349 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 4.84e-06 | 2 | 77 | 2 | 15033925 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 4.84e-06 | 2 | 77 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 4.84e-06 | 2 | 77 | 2 | 1852206 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 4.84e-06 | 2 | 77 | 2 | 18618700 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10359653 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 4.84e-06 | 2 | 77 | 2 | 17118445 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18417613 | ||
| Pubmed | [Identification of novel metastasis associated genes MAG-1 and MAG-2]. | 4.84e-06 | 2 | 77 | 2 | 21310131 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 4.84e-06 | 2 | 77 | 2 | 11500519 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 10825173 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 11171121 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 19332778 | ||
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.66e-08 | 3 | 55 | 3 | 287 | |
| GeneFamily | Na+/K+ transporting ATPase interacting | 1.06e-07 | 4 | 55 | 3 | 659 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.49e-05 | 337 | 70 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.80e-08 | 97 | 77 | 6 | 7b17dc28454949a23701ab127300a29a8899d7d6 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.80e-08 | 97 | 77 | 6 | 4b74b3c5b9590a8215b7370b37e9723e9f040b9c | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.11e-08 | 122 | 77 | 6 | d4152c45dfbb979ddf8380b4896db753a79cad9e | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.11e-08 | 122 | 77 | 6 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.11e-08 | 122 | 77 | 6 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.11e-08 | 122 | 77 | 6 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.11e-08 | 122 | 77 | 6 | 40f983623c990203df4ba997e296231489d51012 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.84e-08 | 124 | 77 | 6 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.42e-07 | 137 | 77 | 6 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-07 | 168 | 77 | 6 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 187 | 77 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 187 | 77 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 187 | 77 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 195 | 77 | 6 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 195 | 77 | 6 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 195 | 77 | 6 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-06 | 195 | 77 | 6 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.43e-06 | 111 | 77 | 5 | 4a22732094a9781867d501d9c05ba652c2f25048 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.71e-06 | 115 | 77 | 5 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.00e-06 | 129 | 77 | 5 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.00e-06 | 129 | 77 | 5 | 98a5f24de72d2ae6a57787226b2e523ddd13b2c5 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.36e-06 | 132 | 77 | 5 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.36e-06 | 132 | 77 | 5 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.67e-06 | 70 | 77 | 4 | b159435487b90331d2d276f182fc8aedf88d612c | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.67e-06 | 70 | 77 | 4 | 7e09547b73789d789c3c464689f7998445830238 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.67e-06 | 70 | 77 | 4 | b486f7fe68743e3385809cfd64512da2f31074df | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Il33_(Il33)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.67e-06 | 70 | 77 | 4 | 8ee9c9c78eec9dc0cec364ee7c9bc6f34d37de76 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-06 | 153 | 77 | 5 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 158 | 77 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 158 | 77 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr-Oligodendrocyte.Tfr.Sez6_(Sez6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-06 | 76 | 77 | 4 | 2b1d7bafad3d9a01fc47790418160950330576c5 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE-O2-Tfr-Oligodendrocyte.Tfr.Sez6_(Sez6)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-06 | 76 | 77 | 4 | 322c3a4c3abdc419f162861ecd52c0ad6ef2381c | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 166 | 77 | 5 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 80 | 77 | 4 | 0d5770c81a223148e57d625ac2c2ae69ab55b36e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 80 | 77 | 4 | 413796630e7aeff7c68a69dd2d9b8cd8f56163b4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 173 | 77 | 5 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 173 | 77 | 5 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-05 | 173 | 77 | 5 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | Frontal_cortex-Macroglia|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 173 | 77 | 5 | ac70145e093ef0df43811e7c67a865ccdd45a5e3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 174 | 77 | 5 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 175 | 77 | 5 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 1.44e-05 | 178 | 77 | 5 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.44e-05 | 178 | 77 | 5 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 1.48e-05 | 179 | 77 | 5 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 179 | 77 | 5 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.48e-05 | 179 | 77 | 5 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 179 | 77 | 5 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 179 | 77 | 5 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 1.48e-05 | 179 | 77 | 5 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-05 | 181 | 77 | 5 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 181 | 77 | 5 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 181 | 77 | 5 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 87 | 77 | 4 | f04125fdfa102c0ab30c2fbff874de3bc2edc3af | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.58e-05 | 87 | 77 | 4 | 8794ac69e8db0c396c0cfc3ee303550c18a6442d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 184 | 77 | 5 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19_Moderate-HSPC|World / disease group, cell group and cell class | 1.69e-05 | 184 | 77 | 5 | ccc93babe1fcdeb66b78e1d8414357877a7c45bd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 185 | 77 | 5 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 188 | 77 | 5 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 189 | 77 | 5 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 190 | 77 | 5 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.97e-05 | 190 | 77 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.97e-05 | 190 | 77 | 5 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-05 | 190 | 77 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.98e-05 | 92 | 77 | 4 | 0754a79efc4c0659d9a2acfe4185bcae1a3e7206 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.98e-05 | 92 | 77 | 4 | aee1fd2419dc1fc7039c0ac56f0ba23ed11d668f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 191 | 77 | 5 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 191 | 77 | 5 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-05 | 192 | 77 | 5 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-05 | 192 | 77 | 5 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-05 | 192 | 77 | 5 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 194 | 77 | 5 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-05 | 195 | 77 | 5 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.23e-05 | 195 | 77 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.23e-05 | 195 | 77 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-05 | 195 | 77 | 5 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Mbp_(Mbp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 96 | 77 | 4 | 9673d03916705c675686bb4282dedd3dc5e98625 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Mbp_(Mbp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 96 | 77 | 4 | 7e2810f5f5a17fcc7ae40edfd3e885740b575e29 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-05 | 199 | 77 | 5 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-05 | 199 | 77 | 5 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-05 | 200 | 77 | 5 | 792fef1f3e47ce5c131fedfad55075fc254aeead | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 4.75e-05 | 115 | 77 | 4 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.25e-05 | 118 | 77 | 4 | d0dd5c882cd9e0a5eb0cb08e47877292126bd4ae | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.25e-05 | 118 | 77 | 4 | 4283699cb3ca7a112faa07727dfdc0b0a67fb779 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.42e-05 | 119 | 77 | 4 | 7367b6e4906d234ca864075443efe420ee407421 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.42e-05 | 119 | 77 | 4 | 0c9aff5442a1b1e51e142d6527d5a48211d94335 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1-P1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.42e-05 | 119 | 77 | 4 | 0dd72dbded7ade911612d20e0c6e3f40e85fc890 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(3)_72hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 8.36e-05 | 133 | 77 | 4 | 32c6a00671af309c4b0b90e93549733729684c61 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.36e-05 | 133 | 77 | 4 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocye.Tnr.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.60e-05 | 134 | 77 | 4 | bc550d3b44f1e1e1c18971c110e816bcffd79d14 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.60e-05 | 134 | 77 | 4 | 90a34ae53a602a92f6f998e7cf061d8f4f0da527 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.37e-05 | 137 | 77 | 4 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.91e-05 | 139 | 77 | 4 | 789edd3c98e7c5c1cc402c780fded9a9dfd1dfb8 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-04 | 146 | 77 | 4 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 146 | 77 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 147 | 77 | 4 | a21b63d0d3aec9ffadf3fac833a0a24da58a95bf | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-04 | 150 | 77 | 4 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| Drug | 2-hydroxycarbazole | 3.43e-08 | 3 | 75 | 3 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 3.43e-08 | 3 | 75 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.43e-08 | 3 | 75 | 3 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.43e-08 | 3 | 75 | 3 | CID005748312 | |
| Drug | 8N3-cADPR | 3.43e-08 | 3 | 75 | 3 | CID000127713 | |
| Drug | aminodantrolene | 3.43e-08 | 3 | 75 | 3 | CID009570289 | |
| Drug | PCB74 | 1.37e-07 | 4 | 75 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.37e-07 | 4 | 75 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.37e-07 | 4 | 75 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.37e-07 | 4 | 75 | 3 | CID000035682 | |
| Drug | dipyrone | 2.04e-07 | 40 | 75 | 5 | CID000003110 | |
| Drug | europium | 4.26e-07 | 87 | 75 | 6 | CID000023981 | |
| Drug | etridiazole | 6.39e-07 | 50 | 75 | 5 | CID000017432 | |
| Drug | MBED | 6.82e-07 | 6 | 75 | 3 | CID000129958 | |
| Drug | chloro-m-cresol | 6.82e-07 | 6 | 75 | 3 | CID000012008 | |
| Drug | AC1O528X | 6.82e-07 | 6 | 75 | 3 | CID006475857 | |
| Drug | NSC114784 | 6.82e-07 | 6 | 75 | 3 | CID000419425 | |
| Drug | borate | 8.63e-07 | 98 | 75 | 6 | CID000007628 | |
| Drug | Azumoleno | 1.19e-06 | 7 | 75 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 1.19e-06 | 7 | 75 | 3 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.19e-06 | 7 | 75 | 3 | CID009547999 | |
| Drug | PCB 95 | 4.05e-06 | 10 | 75 | 3 | CID000038012 | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HG-U133A | 4.35e-06 | 200 | 75 | 7 | 252_UP | |
| Drug | PCB 66 | 5.56e-06 | 11 | 75 | 3 | CID000036185 | |
| Drug | R 478 | 5.56e-06 | 11 | 75 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 5.56e-06 | 11 | 75 | 3 | CID003081323 | |
| Drug | Ryanodine | 7.39e-06 | 12 | 75 | 3 | ctd:D012433 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.07e-05 | 2 | 75 | 2 | ctd:C005147 | |
| Drug | FPL 64176 | 1.52e-05 | 15 | 75 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 1.52e-05 | 15 | 75 | 3 | CID000125015 | |
| Drug | ts M | 1.89e-05 | 48 | 75 | 4 | CID000428025 | |
| Drug | kazinol B | 2.26e-05 | 17 | 75 | 3 | CID000480869 | |
| Drug | methylcoumarin | 2.70e-05 | 18 | 75 | 3 | CID000007092 | |
| Drug | AC1L380G | 3.20e-05 | 19 | 75 | 3 | CID000084698 | |
| Drug | AC1MW7VF | 3.20e-05 | 19 | 75 | 3 | CID000414699 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 3.21e-05 | 3 | 75 | 2 | CID000080262 | |
| Drug | flubendiamide | 3.21e-05 | 3 | 75 | 2 | CID011193251 | |
| Drug | indo-1/AM | 4.38e-05 | 21 | 75 | 3 | CID000123918 | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 4.63e-05 | 196 | 75 | 6 | 2844_DN | |
| Drug | methyl methacrylate | 5.80e-05 | 23 | 75 | 3 | CID000006658 | |
| Drug | A-30 | 6.40e-05 | 4 | 75 | 2 | CID003028528 | |
| Drug | GMA-EDMA | 6.40e-05 | 4 | 75 | 2 | CID003082335 | |
| Drug | Bastadin 10 | 6.40e-05 | 4 | 75 | 2 | CID009589366 | |
| Drug | polyethylenimine | 6.54e-05 | 128 | 75 | 5 | CID000009033 | |
| Drug | T0702 | 7.49e-05 | 25 | 75 | 3 | CID000005908 | |
| Drug | lanthanum | 8.72e-05 | 136 | 75 | 5 | CID000023926 | |
| Drug | A 68930 | 1.06e-04 | 5 | 75 | 2 | ctd:C065380 | |
| Drug | Bicuculline | 1.18e-04 | 29 | 75 | 3 | ctd:D001640 | |
| Drug | 2,4-xylidinothiazoline | 1.31e-04 | 30 | 75 | 3 | CID000099296 | |
| Drug | LOPAC | 1.31e-04 | 30 | 75 | 3 | CID000062696 | |
| Drug | Fura-2AM | 1.35e-04 | 79 | 75 | 4 | CID000105091 | |
| Drug | lead compounds | 1.38e-04 | 150 | 75 | 5 | CID000073212 | |
| Drug | M-HN | 1.44e-04 | 31 | 75 | 3 | CID000015450 | |
| Drug | lindane | 1.56e-04 | 154 | 75 | 5 | CID000000727 | |
| Drug | M3/M4 | 1.59e-04 | 32 | 75 | 3 | CID000486507 | |
| Drug | rosavin | 1.59e-04 | 32 | 75 | 3 | ctd:C529148 | |
| Drug | NSC692750 | 1.59e-04 | 6 | 75 | 2 | CID000078910 | |
| Drug | CNS 1145 | 1.74e-04 | 33 | 75 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.74e-04 | 33 | 75 | 3 | CID000162753 | |
| Drug | lysosphingomyelin | 1.87e-04 | 160 | 75 | 5 | CID000005263 | |
| Drug | mag-indo-1 | 2.22e-04 | 7 | 75 | 2 | CID000131881 | |
| Drug | CHEBI:564108 | 2.22e-04 | 7 | 75 | 2 | CID006400637 | |
| Drug | fodipir | 2.27e-04 | 36 | 75 | 3 | CID000060683 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.46e-04 | 37 | 75 | 3 | CID000009643 | |
| Drug | mag-fura-2 | 2.46e-04 | 37 | 75 | 3 | CID000123839 | |
| Drug | 4-chloro-m-cresol | 2.46e-04 | 37 | 75 | 3 | CID000001732 | |
| Drug | ruthenium | 2.65e-04 | 94 | 75 | 4 | CID000023950 | |
| Drug | AC1L98DX | 2.67e-04 | 38 | 75 | 3 | CID000439957 | |
| Drug | NAADP | 2.88e-04 | 39 | 75 | 3 | CID000123952 | |
| Drug | NSC-71964 | 2.96e-04 | 8 | 75 | 2 | CID000025306 | |
| Drug | SM-9 | 2.96e-04 | 8 | 75 | 2 | CID000486038 | |
| Drug | methyl-beta-cyclodextrin | 2.96e-04 | 8 | 75 | 2 | CID000162771 | |
| Drug | indo-1 | 3.23e-04 | 99 | 75 | 4 | CID000105060 | |
| Drug | acrylic acid | 3.34e-04 | 41 | 75 | 3 | CID000006581 | |
| Drug | Dantrolene | 3.34e-04 | 41 | 75 | 3 | ctd:D003620 | |
| Drug | dimethylhydrazine | 3.34e-04 | 41 | 75 | 3 | CID000005976 | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.66e-04 | 185 | 75 | 5 | 6243_UP | |
| Drug | lactosyl lysosphingolipid | 3.80e-04 | 9 | 75 | 2 | CID006439268 | |
| Drug | isophorone | 3.80e-04 | 9 | 75 | 2 | CID000006544 | |
| Drug | FLA 365 | 3.80e-04 | 9 | 75 | 2 | CID000072776 | |
| Drug | Pyoverdin | 3.85e-04 | 43 | 75 | 3 | CID005289234 | |
| Drug | escina | 4.13e-04 | 44 | 75 | 3 | CID006433489 | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.13e-04 | 190 | 75 | 5 | 6697_UP | |
| Drug | phosphine oxide | 4.34e-04 | 107 | 75 | 4 | CID000166931 | |
| Drug | 4,4'-dithiodipyridine | 4.41e-04 | 45 | 75 | 3 | CID000075846 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 5599_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 3604_DN | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.54e-04 | 194 | 75 | 5 | 4117_UP | |
| Drug | NSC3260 | 4.65e-04 | 195 | 75 | 5 | CID000220461 | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.65e-04 | 195 | 75 | 5 | 2624_UP | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.65e-04 | 195 | 75 | 5 | 4399_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.65e-04 | 195 | 75 | 5 | 3923_DN | |
| Drug | Flrf Peptide | 4.74e-04 | 10 | 75 | 2 | CID000129588 | |
| Drug | AC1N38XE | 4.74e-04 | 10 | 75 | 2 | CID004060965 | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 5022_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 2270_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 3567_DN | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 3372_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 7371_UP | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.76e-04 | 196 | 75 | 5 | 2506_DN | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.45e-08 | 3 | 73 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.45e-08 | 3 | 73 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.81e-05 | 3 | 73 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 3.61e-05 | 4 | 73 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Aortic Rupture | 6.01e-05 | 5 | 73 | 2 | C0003496 | |
| Disease | Aortic Aneurysm, Ruptured | 6.01e-05 | 5 | 73 | 2 | C0741160 | |
| Disease | tissue plasminogen activator measurement | 2.15e-04 | 9 | 73 | 2 | EFO_0004791 | |
| Disease | alopecia areata (is_marker_for) | 2.68e-04 | 10 | 73 | 2 | DOID:986 (is_marker_for) | |
| Disease | glycerate measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0021029 | |
| Disease | triacylglycerol 52:3 measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0010415 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.04e-03 | 80 | 73 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | exercise test | 1.11e-03 | 20 | 73 | 2 | EFO_0004328 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.41e-03 | 195 | 73 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | hearing impairment | 1.87e-03 | 98 | 73 | 3 | C1384666 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.04e-03 | 27 | 73 | 2 | DOID:8552 (is_marker_for) | |
| Disease | executive function measurement | 2.42e-03 | 376 | 73 | 5 | EFO_0009332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVVLNGCCSVFCALA | 236 | Q4AC99 | |
| ICLCFGTVVCSVLDI | 71 | Q01362 | |
| RAGRAVVSCPAACLC | 26 | Q86WK6 | |
| ALRGVCSCVEAGKAC | 1471 | P26358 | |
| RCCKALTGIDLSVCT | 526 | Q8IX12 | |
| CRSAAQVCLCLGQLE | 1651 | Q9UIF9 | |
| CLEGIRCAIRIACIF | 976 | Q9Y6D6 | |
| CTCSILHLCVIALDR | 106 | P28566 | |
| CLEGIRCAIRIACIF | 921 | Q9Y6D5 | |
| DLASKCQAVICCRVT | 901 | O60423 | |
| CGFVILAACVVACVG | 76 | O75071 | |
| ASITVLCIACPCSLG | 991 | Q04656 | |
| VCAVLALVCCASGLF | 26 | Q8NFF2 | |
| GLGCCELAIALECRQ | 101 | O95980 | |
| ACIAVCSARILCIGA | 1541 | Q96PE2 | |
| SLTLEVCQCDNRGIC | 581 | P32926 | |
| GRCSLICLCALQLVS | 6 | Q8N8D7 | |
| LGAQVCQLERLCCTG | 246 | Q86XE5 | |
| CAAARDTVQCLCVVK | 421 | P20916 | |
| KNLACSGICASLVCV | 81 | Q14439 | |
| CLTENCCSALGRVLL | 786 | P59045 | |
| CALSLAACLCLVARR | 186 | Q96N19 | |
| TCCCVISVRGLAQAQ | 101 | Q96I76 | |
| EVIGRTGLAIICCCV | 141 | Q8NH59 | |
| RVVVLCVACGFCSLL | 6 | Q4G148 | |
| GTSLLISCAKCCVRV | 711 | Q9H3R0 | |
| CCLCCHVRTGTILLG | 106 | Q86VI4 | |
| AVRACHKVCRCLLSG | 6 | Q9UHN1 | |
| CLCIVLSFLEGVGCL | 6 | Q3SXY7 | |
| CAVCDKTCGSVLRLQ | 261 | Q86XP1 | |
| VCATCINASRAVKCL | 1811 | Q2PPJ7 | |
| CIVLQCGADSLGCDR | 251 | O15379 | |
| GCAAFVVVCILGCIL | 146 | Q9Y6W8 | |
| SVCGLTICAAIICTL | 176 | P81408 | |
| TICAAIICTLSAIVC | 181 | P81408 | |
| VTALLCCGLCNGVLI | 566 | Q8N6C5 | |
| ISCLLSGIACACAVI | 86 | O95500 | |
| SIRAIGCFRELCALC | 1266 | Q9H799 | |
| NLRAFGIVECVLCTC | 276 | Q9BU40 | |
| LTCCRICVRALSGTI | 196 | Q53EU6 | |
| GIVCTKTLCCATVGR | 201 | P35555 | |
| LVCSDCGCVVTEGVL | 26 | Q9HAW0 | |
| CLNLFGVCRTDVCNI | 31 | Q30KR1 | |
| VCLAAVGLVGDLCRA | 666 | Q14974 | |
| RCACSSIVVKNCLLA | 316 | Q8IYD2 | |
| CVALLCRPLCGVSTC | 41 | P60329 | |
| VALACCFVAAAVALR | 16 | O00519 | |
| CALALCVAVAIVAGA | 6 | P22607 | |
| GIVCTKTLCCATIGR | 231 | P35556 | |
| SREVCRAVLSFLCCG | 311 | O95977 | |
| VLCSLCVCNGVAVRS | 601 | P21817 | |
| LDVLCSLCVCHGVAV | 611 | Q92736 | |
| VVRTACCEGLVALVA | 61 | Q5VW36 | |
| GACLSISCFICIVIS | 201 | Q96R54 | |
| CGTVCSLIHLCLALR | 151 | Q8NGL2 | |
| FCVRVCSGCAVLAVL | 186 | Q8NC44 | |
| VAFIILGSLVAACCC | 126 | Q6UWI4 | |
| GRCTLVAFCCLQLVA | 6 | Q4KMZ8 | |
| CCLVSEGLCRLLGQE | 721 | Q9NRP7 | |
| ASINLCVVICKRCAG | 561 | Q96P48 | |
| VGGSLCLTAVIVCCI | 111 | Q8IZ96 | |
| GRCALVVLCAFQLVA | 6 | Q8IVV8 | |
| CSSKAVVSLRCIACG | 231 | O15393 | |
| RGLCCVLLLCGAVFV | 6 | P00750 | |
| LCCAVICLLGAGLSN | 6 | A0A087X0M5 | |
| LCSLCLCNGVAVRAN | 601 | Q15413 | |
| GGKIVTRICCLCCLN | 571 | Q9P2H5 | |
| KCVRTVITRECCAGF | 1326 | Q8WWQ8 | |
| TAVSQSRICLCAVLC | 11 | O75678 | |
| VSSCCLHICQGIRGL | 66 | Q9P0L9 | |
| IIGCCGIALTAECIF | 21 | O75841 | |
| ACRLAENCVCGLTTR | 56 | Q00G26 | |
| CARCVGLSLITLCLV | 6 | O14894 | |
| VLANFLIICCLCGSG | 431 | Q8TDI7 | |
| VAALLCGAVVLCLQC | 61 | Q6UWW9 | |
| CGQGVRTRLLSCVCS | 1201 | Q9C0I4 | |
| ALIGQLVVCTLCSCV | 126 | Q96MT1 | |
| LCAAALLCVCRPGAV | 6 | Q5R3F8 | |
| CCARCLVGAPFASLV | 6 | P60201 |